Get the app!
Back to Trades

Coyne Terrance P.

EVP & CFOCIK 0001814876

Largest Purchase

No open-market purchases in the recent filings.

Profile

Filings
14
Buy transactions
0
Sell transactions
31
Companies
1
Active
2025–2026

Coyne Terrance P., EVP & CFO, has filed 14 SEC reports (2025–2026), all concentrated in Royalty Pharma plc (RPRX), totaling $34.7M in disclosed volume. Weighing $0 bought versus $34.7M sold, the history is heavily weighted toward selling. Data is sourced from official SEC Form 3, 4, and 5 filings.

Trading History

14 loaded
Aug 17RPRX
Royalty Pharma plc
Coyne Terrance P.EVP & CFOSell$645.6K
Aug 7RPRX
Royalty Pharma plc
Coyne Terrance P.EVP & CFOGrant$0
May 28RPRX
Royalty Pharma plc
Coyne Terrance P.EVP & CFOSell$3.5M
Apr 30RPRX
Royalty Pharma plc
Coyne Terrance P.EVP & CFOSell$1.7M
Apr 2RPRX
Royalty Pharma plc
Coyne Terrance P.EVP & CFOSell$1.7M
Mar 25RPRX
Royalty Pharma plc
Coyne Terrance P.EVP & CFOSell$1.6M
Mar 4RPRX
Royalty Pharma plc
Coyne Terrance P.EVP & CFOSell$1.6M
Feb 4RPRX
Royalty Pharma plc
Coyne Terrance P.EVP & CFOSell$10.4M
Jan 23RPRX
Royalty Pharma plc
Coyne Terrance P.EVP & CFOSell$2.7M
Dec 17RPRX
Royalty Pharma plc
Coyne Terrance P.EVP & CFOSell$2.7M
Dec 3RPRX
Royalty Pharma plc
Coyne Terrance P.EVP & CFOSell$2.8M
Nov 26RPRX
Royalty Pharma plc
Coyne Terrance P.EVP & CFOSell$2.7M
Nov 19RPRX
Royalty Pharma plc
Coyne Terrance P.EVP & CFOSell$2.7M
Aug 8RPRX
Royalty Pharma plc
Coyne Terrance P.EVP & CFOGrant$0

14 filings